Cost of Illness from the Public Payers’ Perspective in Patients with Ankylosing Spondylitis in Rheumatological Care

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Rheumatology

• Publication date

  2010-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3899/jrheum.100099PMID 20716657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.

  2008cited by this paper
• The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit.

  2008cited by this paper
• The burden of ankylosing spondylitis in Spain.

  2008cited by this paper
• Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis.

  2007cited by this paper
• Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

  2006cited by this paper
• A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis

  2006cited by this paper
• Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health.

  2006cited by this paper
• Costs and quality of life of patients with ankylosing spondylitis in Canada.

  2006cited by this paper
• Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions.

  2005cited by this paper
• Review of the costs of illness of ankylosing spondylitis and methodologic notes

  2005cited by this paper
• Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

  2005cited by this paper
• The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).

  2004cited by this paper
• Impact of anti-tumour necrosis factor α treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis

  2004cited by this paper
• Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis

  2004cited by this paper
• Costs of ankylosing spondylitis in three European countries: the patient’s perspective

  2003cited by this paper
• Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries

  2003influential reference
• Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries

  2002cited by this paper
• Functional disability predicts total costs in patients with ankylosing spondylitis.

  2002cited by this paper
• Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.

  2002cited by this paper
• Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis.

  2001cited by this paper
• Work disability among people with ankylosing spondylitis.

  2001cited by this paper
• Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients

  2001cited by this paper
• Risk factors for work disability in patients with ankylosing spondylitis.

  2001cited by this paper
• Withdrawal from labour force due to work disability in patients with ankylosing spondylitis

  2001cited by this paper
• The outcome of ankylosing spondylitis: a study of 100 patients.

  1997cited by this paper
• A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us?

  1997cited by this paper
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

  1984cited by this paper
• Ankylosing spondylitis: a comparative study of patients in an epidemiological survey, and those admitted to a department of rheumatology.

  1984cited by this paper

• Development of a Physiotherapist-Coordinated Interdisciplinary Rehabilitation Intervention for People with Suspected Axial Spondyloarthritis: The SPINCODE Rehabilitation Intervention

  2024cites this paper
• The economic burden of diseases in the Nordic countries: A systematic review

  2023cites this paper
• To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question.

  2023cites this paper
• Effectiveness and cost-effectiveness of combined asynchronous telemonitoring and patient-initiated care for spondyloarthritis: protocol for a pragmatic multicentre randomised controlled trial (TeleSpA Study)

  2023cites this paper
• Biologic use in psoriatic arthritis and ankylosing spondylitis patients: a descriptive epidemiological study using linked, routine data in Wales, UK

  2021cites this paper
• Costs of disease: The perspective matters

  2021cites this paper
• The employment gap: the relationship between medical student career choices and the future needs of the New Zealand medical workforce.

  2019cites this paper
• Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net)

  2019cites this paper
• Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO‐VADIS study, a large, prospective real‐life cohort

  2019cites this paper
• The costs associated with ankylosing spondylitis/axial spondyloarthritis in Aotearoa/New Zealand.

  2019cites this paper
• Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

  2018cites this paper
• Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy

  2018cites this paper
• Efficiency of dose reduction strategy of etanercept in patients with axial spondyloarthritis.

  2018cites this paper
• Spinal fractures related to ankylosing spondylitis : Epidemiology, clinical outcome and biomechanics

  2017cites this paper
• Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis

  2017cites this paper
• Economic evaluations in the context of treatment recommendations in spondyloarthritis : analyses from the DESIR cohort

  2017cites this paper
• The Link Between Quality of Life and Economic Issues in Ankylosing Spondylitis.

  2016cites this paper
• Cost of arthritis: a systematic review of methodologies used for direct costs

  2016influential citation
• A 6-year trend of the healthcare costs of arthritis in a population-based cohort of older women

  2016cites this paper
• Costs of Drug Therapy in Patients with Ankylosing Spondylitis in Brazil

  2016cites this paper
• The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis

  2015influential citation
• Förstudie om Grön rehabilitering på landsbygden

  2015cites this paper
• Predictors of Presenteeism and Activity Impairment Outside Work in Patients with Spondyloarthritis

  2015cites this paper
• The Cost of Ankylosing Spondylitis in the UK Using Linked Routine and Patient-Reported Survey Data

  2015cites this paper
• The risk for depression in patients with ankylosing spondylitis: a population-based cohort study

  2014cites this paper
• Costs and work limitation of patients with ankylosing spondylitis in China.

  2014cites this paper
• Validity of Diagnostic Codes and Prevalence of Physician-Diagnosed Psoriasis and Psoriatic Arthritis in Southern Sweden – A Population-Based Register Study

  2014cites this paper
• Patterns in healthcare consultations

  2013cites this paper
• The Socio-economic Impacts on Household Income, Employment Status, Need for Public Assistance, and Marriage Opportunities in Patients with Spondyloarthritis: A Comparison with the Hong Kong Population

  2013cites this paper
• Pourquoi un diagnostic et une prise en charge précoces des spondyloarthrites

  2013cites this paper
• Work productivity in a population-based cohort of patients with spondyloarthritis.

  2013cites this paper
• Early diagnosis and management are crucial in spondyloarthritis.

  2013cites this paper
• Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden

  2013cites this paper
• Prevalence, physical activity and work in patients with spondyloarthritis

  2013cites this paper
• Back and neck pain: Patterns in healthcare consultations

  2013cites this paper
• Economic Considerations of the Treatment of Ankylosing Spondylitis

  2012cites this paper
• Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study.

  2012cites this paper
• Team rehabilitation and health care utilization in chronic inflammatory arthritis patients

  2012cites this paper
• Variability in Resource Consumption in Patients With Spondyloarthritis in Spain. Preliminary Descriptive Data From the emAR II Study

  2012cites this paper
• A systematic literature review of the economic impact of ankylosing spondylitis.

  2012influential citation
• UNIVERZITET U NOVOM SADU

  2008cites this paper